When and why should patients with hematologic malignancies see a palliative care specialist?

Hematology (United States)

Volumn 2015, Issue 1, 2015, Pages 471-478

  LeBlanc, Thomas W ^a   El Jawahri, Areej ^b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER PALLIATIVE THERAPY; CANCER PATIENT; EVIDENCE BASED PRACTICE; HEMATOLOGIC MALIGNANCY; HOPE; HUMAN; MEDICAL SPECIALIST; PERSONAL EXPERIENCE; REVIEW; ATTITUDE TO HEALTH; DECISION MAKING; EVIDENCE BASED MEDICINE; HEMATOLOGIC NEOPLASMS; MANPOWER; ONCOLOGY; PALLIATIVE THERAPY; PATIENT REFERRAL; PROCEDURES; PROGNOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); STANDARDS;

ATTITUDE TO HEALTH; DECISION MAKING; EVIDENCE-BASED MEDICINE; HEMATOLOGIC NEOPLASMS; HUMANS; MEDICAL ONCOLOGY; PALLIATIVE CARE; PROGNOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REFERRAL AND CONSULTATION;

EID: 85010982892     PISSN: 15204391     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation-2015.1.471     Document Type: Review

References (46)

1. CAPC. What Is Palliative Care? (http://getpalliativecare.org/whatis/). Accessed May 1, 2015.
2. Jacobsen J, Jackson V, Dahlin C, et al. Components of early outpatient palliative care consultation in patients with metastatic nonsmall cell lung cancer. J Palliat Med. 2011;14(4):459-464.
3. Bakitas M, Lyons KD, Hegel MT, et al. Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial. JAMA. 2009;302(7):741-749.
4. Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733-742.
5. Bakitas MA, Tosteson TD, Li Z, et al. Early versus delayed initiation of concurrent palliative oncology care: patient outcomes in the ENABLE III randomized controlled trial. J Clin Oncol. 2015;33(13):1438-1445.
6. Dionne-Odom JN, Azuero A, Lyons KD, et al. Benefits of early versus delayed palliative care to informal family caregivers of patients with advanced cancer: outcomes from the ENABLE III randomized controlled trial. J Clin Oncol. 2015;33(13):1446-1452.
7. Howell DA, Shellens R, Roman E, Garry AC, Patmore R, Howard MR. Haematological malignancy: are patients appropriately referred for specialist palliative and hospice care? A systematic review and metaanalysis of published data. Palliat Med. 2011;25(6):630-641.
8. Epstein AS, Goldberg GR, Meier DE. Palliative care and hematologic oncology: the promise of collaboration. Blood Rev. 2012;26(6):233-239.
9. Manitta V, Zordan R, Cole-Sinclair M, Nandurkar H, Philip J. The symptom burden of patients with hematological malignancy: a crosssectional observational study. J Pai Symptom Manage. 2011;42(3):432-442.
10. LeBlanc TW. Palliative care and hematologic malignancies: old dog, new tricks? J Clin Oncol. 2014;10(6):e404-e407.
11. WHO. Definition of Palliative Care (http://www.who.int/cancer/palliative/definition/en/). Accessed May 1, 2015.
12. Smith TJ, Temin S, Alesi ER, et al. American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol. 2012;30(8):880-887.
13. Hideshima T, Chauhan D, Podar K, Schlossman RL, Richardson P, Anderson KC. Novel therapies targeting the myeloma cell and its bone marrow microenvironment. Semin Oncol 2001;28(6):607-612.
14. CAPC. Palliative care growth trend continues, according to latest center to advance palliative care analysis (https://www.capc.org/about/pressmedia/press-releases/2014-9-2/palliative-care-growth-trend-continuesaccording-latest-center-advance-palliative-care-analysis/). Accessed June 18, 2014.
15. CAPC. a state-by-state report card on access to palliative care in our Nation's hospitals (http://reportcard.capc.org/findings). Accessed May 1, 2015.
16. Quill TE, Abernethy AP. Generalist plus specialist palliative care: creating a more sustainable model. N Engl J Med. 2013;368(13):1173-1175.
17. Lupu D, American Academy of H; Palliative Medicine Workforce Task F. Estimate of current hospice and palliative medicine physician workforce shortage. J Pain Symptom Manage. 2010;40(6):899-911.
18. Back AL, Park ER, Greer JA, et al. Clinician roles in early integrated palliative care for patients with advanced cancer: a qualitative study. J Palliat Med. 2014;17(11):1244-8.
19. Yoong J, Park ER, Greer JA, et al. Early palliative care in advanced lung cancer: a qualitative study. JAMA Intern Med. 2013;173(4):283-290.
20. Jackson VA, Jacobsen J, Greer JA, Pirl WF, Temel JS, Back AL. The cultivation of prognostic awareness through the provision of early palliative care in the ambulatory setting: a communication guide. J Palliat Med.2013;16(8):894-900.
21. Schenker Y, Crowley-Matoka M, Dohan D, et al. Oncologist factors that influence referrals to subspecialty palliative care clinics. J Oncol. 2014;10(2):e37-e44.
22. Buss MK, Lessen DS, Sullivan AM, Von Roenn J, Arnold RM, Block SD. Hematology/oncology fellows' training in palliative care: results of a national survey. Cancer. 2011;117(18):4304-4311.
23. Ferrell B, Connor SR, Cordes A, et al. The national agenda for quality palliative care: the National Consensus Project and the National Quality Forum. J Pain Symptom Manage. 2007;33(6):737-744.
24. Temel JS, Greer JA, Admane S, et al. Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer: results of a randomized study of early palliative care. J Clin Oncol. 2011;29(17):2319-2326.
25. Zimmermann C, Swami N, Krzyzanowska M, et al. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet. 2014;383(9930):1721-1730.
26. Pirl WF, Temel JS, Billings A, et al. Depression after diagnosis of advanced non-small cell lung cancer and survival: a pilot study. Psychosomatics. 2008;49(3):218-224.
27. Maione P, Perrone F, Gallo C, et al. Pretreatment quality-of-life and functional status assessment significantly predict survival of elderly patients with advanced non-small-cell lung cancer receiving chemotherapy: a prognostic analysis of the multicenter Italian lung cancer in the elderly study. J Clin Oncol. 2005;23(28):6865-6872.
28. Movsas B, Moughan J, Sarna L, et al. Quality-of-life supersedes the classic prognosticators for long-term survival in locally advanced non-small-cell lung cancer: an analysis of RTOG 9801. J Clin Oncol. 2009;27(34):5816-5822.
29. Wood WA, Le-Rademacher J, Fei M, et al. Patient-reported quality-oflife is an independent predictor of survival after allogeneic hematopoietic cell transplantation: a secondary analysis from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902: Abstract presented at ASH Annual Meeting, December 7, 2014, San Francisco, C.A.
30. Fadul NA, El Osta B, Dalal S, Poulter VA, Bruera E. Comparison of symptom burden among patients referred to palliative care with hematologic malignancies versus those with solid tumors. J Palliat Med. 2008;11(3):422-427.
31. Manitta VJ, Philip JA, Cole-Sinclair MF. Palliative care and the hemato-oncological patient: can we live together? A review of the literature. J Palliat Med. 2010;13(8):1021-1025.
32. El-Jawahri A, Traeger L, Kuzmuk K, et al. Quality-of-life and mood of patients and family caregivers during hospitalization for hematopoietic stem cell transplantation. Cancer. 2014;121(6):951-959.
33. Hui D, Didwaniya N, Vidal M, et al. Quality of end-of-life care in patients with hematologic malignancies: a retrospective cohort study. Cancer. 2014;120(10):1572-1578.
34. El-Jawahri AR, Abel GA, Steensma DP, et al. Health care utilization and end of life care for older patients with acute myeloid leukemia. Cancer. 2015;121(16):2840-2848.
35. Hui D, Didwaniya N, Vidal M, et al. Quality of end-of-life care in patients with hematologic malignancies: a retrospective cohort study. Cancer. 2014;120(10):1572-1578.
36. LeBlanc TW, Abernethy AP, Casarett DJ. What is different about patients with hematologic malignancies? A retrospective cohort study of cancer patients referred to a hospice research network. J Pain Symptom Manage. 2014;49(3):505-512.
37. Howell DA, Roman E, Cox H, et al. Destined to die in hospital? Systematic review and meta-analysis of place of death in haematological malignancy. BMC Palliat Care. 2010;9:9.
38. LeBlanc TW, O'Donnell JD, Crowley-Matoka M, et al. Perceptions of palliative care among hematologic malignancy specialists: a mixedmethods study. J Clin Oncol. 2015;11(2):e230-e238.
39. CAPC. 2011 Public opinion research on palliative care (https://www.capc.org/media/filer-public/18/ab/18ab708c-f835-4380-921dfbf729702e36/2011-public-opinion-research-on-palliative-care.pdf). Accessed May 1, 2015.
40. Bernacki RE, Block SD; American College of Physicians High Value Care Task F. Communication about serious illness care goals: a review and synthesis of best practices. JAMA Intern Med. 2014;174(12):1994-2003.
41. El-Jawahri A, Traeger L, Park ER, et al. Associations among prognostic understanding, quality-of-life, and mood in patients with advanced cancer. Cancer. 2014;120(2):278-285.
42. El-Jawahri A, Traeger L, Kuzmuk K, et al. Prognostic understanding, quality-of-life and mood in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant. 2015;50(8):1119-1124.
43. Apatira L, Boyd EA, Malvar G, et al. Hope, truth, and preparing for death: perspectives of surrogate decision makers. Ann Intern Med. 2008;149(12):861-868.
44. LeBlanc TW. In the sandbox: palliative care and hematologic malignancies. J Commun Support Oncol. 2014;12(2):44-45.
45. Odejide OO, Salas Coronado DY, Watts CD, Wright AA, Abel GA. End-of-life care for blood cancers: a series of focus groups with hematologic oncologists. J Clin Oncol. 2014;10(6):e396-e403.
46. Uceda Torres ME, Rodriguez Rodriguez JN, Sanchez Ramos JL, Alvarado Gomez F. Transfusion in palliative cancer patients: a review of the literature. J Palliat Med. 2014;17(1):88-104.